LIORESAL Drug Patent Profile

✉ Email this page to a colleague

When do Lioresal patents expire, and when can generic versions of Lioresal launch?

Lioresal is a drug marketed by Amneal and Novartis and is included in two NDAs.

The generic ingredient in LIORESAL is baclofen. There are twenty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the baclofen profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lioresal

A generic version of LIORESAL was approved as baclofen by IVAX SUB TEVA PHARMS on July 21^st, 1988.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LIORESAL?
What are the global sales for LIORESAL?
What is Average Wholesale Price for LIORESAL?

Summary for LIORESAL

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	150
Clinical Trials:	16
Patent Applications:	5,318
Drug Prices:	Drug price information for LIORESAL
What excipients (inactive ingredients) are in LIORESAL?	LIORESAL excipients list
DailyMed Link:	LIORESAL at DailyMed

Drug patent expirations by year for LIORESAL

Recent Clinical Trials for LIORESAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dr. John A. Thiel Medical Professional Corporation	N/A
Prof. Daniele Zullino	Phase 2
Medtronic	Phase 4

See all LIORESAL clinical trials

Pharmacology for LIORESAL

Drug Class	gamma-Aminobutyric Acid-ergic Agonist
Mechanism of Action	GABA A Agonists GABA B Agonists

US Patents and Regulatory Information for LIORESAL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal	LIORESAL	baclofen	INJECTABLE;INTRATHECAL	020075-003	Nov 7, 1996	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	LIORESAL	baclofen	TABLET;ORAL	017851-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal	LIORESAL	baclofen	INJECTABLE;INTRATHECAL	020075-001	Jun 17, 1992	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Amneal	LIORESAL	baclofen	INJECTABLE;INTRATHECAL	020075-002	Jun 17, 1992	AP	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	LIORESAL	baclofen	TABLET;ORAL	017851-003	Jan 20, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LIORESAL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	LIORESAL	baclofen	TABLET;ORAL	017851-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Novartis	LIORESAL	baclofen	TABLET;ORAL	017851-003	Jan 20, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LIORESAL

See the table below for patents covering LIORESAL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
United Kingdom	1017439		⤷ Sign Up
Netherlands	6407755		⤷ Sign Up
Switzerland	449646	Verfahren zur Herstellung neuer Aminosäuren	⤷ Sign Up
France	1431697	Procédé de préparation de nouveaux acides aminés, entre autres l'acide gamma-amino-beta-(p-chlorophényl)butyrique	⤷ Sign Up
France	3692		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LIORESAL

Recent Clinical Trials for LIORESAL

Pharmacology for LIORESAL

Make Better Decisions: Try a trial or see plans & pricing